- Home
- BATL vs SRTS Comparison
BATL vs SRTS Comparison
Compare BATL & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BATL | SRTS |
|---|---|---|
| Founded | 1987 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.6M | 44.3M |
| IPO Year | 2004 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BATL | SRTS |
|---|---|---|
| Price | $1.32 | $2.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 4.1M | 61.3K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $166,043,000.00 | $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $2.66 |
| 52 Week High | $29.70 | $5.92 |
Technical Indicators
Market Signals| Indicator | BATL | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 30.18 | 26.72 |
| Support Level | $1.05 | N/A |
| Resistance Level | $1.51 | $3.35 |
| Average True Range (ATR) | 0.15 | 0.19 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 6.50 | 5.59 |
Price Performance
Historical ComparisonAbout BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.